Alkem Laboratories has informed that this is in reference to earlier intimation dated 4th November, 2026, pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations) regarding holding of Board Meeting on 12th November, 2026 to approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026. The Board of Directors at its meeting held today, i.e. 12th November, 2026 has approved the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the SEBI LODR Regulations is enclosed. The meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 01.40 pm. The above information is also available on the website of the Company at www.alkemlabs.com
The above information is a part of company’s filings submitted to BSE.
